Healthcare and Life Science
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. ...
SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expressionPortfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elementsSheffield, UK, 23 Sept...
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetrationNew distribution channels to improve access to Atelerix’s non-cryogenic cell preservation solutions and strengthen local technical supportNewcastle, UK, 23 Septe...
A leading hospital charity thanks its Daily Mirror Pride of Britain Regional Fundraiser of the Year nominee – saying they "couldn’t be prouder”
This year's Daily Mirror Pride of Britain Awards will be televised live on ITV next month. Prior to all the finalists getting through, they go through a process where regional news teams select a fundraiser from the 17 regions across the UK. For the second year running, a fundraiser f...
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemicCOPD is a silent killer. It is the third leading cause of death worldwide, taking three million lives annually. More than 450 million are diagnosed, and the actual number may reach 900 million when undiagnosed cases are counted. In the EU, COPD costs €38.6 billion annua...
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enoughFor decades, inhalers have been the cornerstone of COPD care. They improve symptoms and prolong life. But adherence is low — often less than 50% — and monitoring is sporadic. Patients are frequently left unobserved for long stretches, during which th...
The smartphone revolution in lung health: Foundations for the future
Spirometry: A century-old tool in need of reinventionFor more than a century, spirometry has been the foundation of respiratory medicine. Yet despite its clinical importance, the test remains hospital-bound, tied to bulky equipment and reliant on maximal voluntary effort. Patients often...
TRIMTECH Therapeutics named as one of Fierce Biotech’s ‘Fierce 15’ for 2025
Fierce 15 highlights pre-commercial biotech companies driving the next generation of therapies for patients worldwide ...
Invent: Life Sciences podcast - Automation, Access, and the Future of Manufacturing
Manufacturing can make or break the future of cell and gene therapy. In this episode, Stuart sits down with two expert guests to share how smart design, automation, and closed systems are helping to lower costs, reduce complexity, and make therapies more accessible. From scaling strateg...
Abselion introduces Protein G Total Antibody Quantification Kit
New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform ...